LSPW
SRNE

Lake Street Private Wealth’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Lake Street Private Wealth’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,200
Closed -$90K – 208
2020
Q4 		$90K Buy
+13,200
New +$106K 0.03% 192

Other funds holding SRNE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Lake Street Private Wealth's SRNE Position: Q1 2021 in Review

Lake Street Private Wealth sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2021, closing a stake of 13,200 shares — an estimated $90K sold.

Lake Street Private Wealth first reported a position in SRNE in Q4 2020 and held it in 1 quarter. The position peaked at $90K in Q4 2020. 231 funds tracked by Wall St. Rank hold SRNE as of Q1 2021.

  • Lake Street Private Wealth reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Lake Street Private Wealth sold 13,200 Sorrento Therapeutics, Inc. shares in Q1 2021, an estimated $90K.
  • Lake Street Private Wealth first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 1 quarter.
  • Lake Street Private Wealth's Sorrento Therapeutics, Inc. position peaked at $90K in Q4 2020.
  • 231 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2021.

Based on Lake Street Private Wealth's 13F filing for Q1 2021, filed 16 Apr 2021.